期刊文献+

RP-HPLC法研究米托蒽醌白蛋白纳米粒在大鼠的体内分布和淋巴结靶向性 被引量:8

Study on the tissue distribution and lymph node targeting of mitoxantrone loaded albumin nanoparticles RP-HPLC method for determination of mitoxantrone in rat plasma and different tissues
下载PDF
导出
摘要 目的:建立大鼠血浆及组织(心、肝、脾、肺、肾及淋巴结)中米托蒽醌(MTO)的快速萃取法和 RP-HPLC 检测法,研究米托蒽醌白蛋白纳米粒(MTO-BSA-NP)在大鼠体内的组织分布和淋巴结靶向性。方法:采用甲酸为酸化剂、甲醇为润湿剂、20%三氯乙酸为蛋白沉淀剂、氯仿为油脂溶解剂一步沉淀萃取 MTO。RP-HPLC 法检测 MTO,色谱柱为 C_(18)(300mm×6mm,5μm),流动相为甲醇-0.16mol·L^(-1)甲酸铵缓冲液(pH2.7)(48:52),进样量10μL,流速1.0mL·min,检测波长658nm,外标法峰面积定量。结果:MTO 与内源性物质分离良好。血浆及心、肺、肾和淋巴结匀浆中,MTO 浓度在50~2997ng·mL^(-1)范围内;肝和脾匀浆中,MTO 浓度在100~2997ng·mL^(-1)范围内,峰面积与 MTO 浓度线性关系良好(r>0.999)。MTO 从血浆中萃取同收率为98.5%,组织中的萃取回收率均在52.0%以上。方法回收率高,日内和日间精密度均小于10%,样品稳定性良好。测定结果表明 MTO-BSA-NP 在淋巴结的摄取率是米托蒽醌注射液(MTO-Soln)的3.36倍,但在其他组织的分布无显著性差异。结论:本文建立的一步沉淀萃取法和 RP-HPLC 法,简便、快速、可靠,可用于 MTO-BSA-NP 在大鼠的体内分布和淋巴结靶向性研究。MTO-BSA-NP 较 MTO-Soln 淋巴结靶向性显著。 Objective:To develop a simple,rapid RP - HPLC method for determination of mitoxantrone(MTO) in rat plasma and different tissues (lymph nodes, liver, spleen, heart, and kidneys) after sc injection of mitoxantrone loaded albumin nanoparticles (MTO- BSA- NP). Methods:One- step protein precipitating procedure was used to prepare samples by adding formic acid and methanol to increase the mitoxantrone extraction recovery, 20% CCl3COOH to precipitate protein and chloroform to dissolve lipids. Assay of mitoxantrone was carried out using C18 reversed phase HPLC column(300 mm × 6 mm,5 μm) , with the mobile phase of methanol -0. 16 mol · L^-1 ammonium formate buffer(pH 2.7) (48: 52) ,injection volumn of 10 μL and flow rate of 1.0 mL · min^-1 at 658 nm by external standard method. Results:Mitoxantrone can be baseline separated with other substances. In plasma,heart, kidney and lymph node,the standard curves were linear from 50 to 2997 ng · mL^-1. In liver and spleen, the standard curves were linear from 100 to 2997 ng · mL^-1. The absolute recovery of mitoxantrone from the plasma was 98.5% and other homogenates were all over 52.0%. The within- day and between- day precision were all below 10%. The samples were stable during the storage, extraction and assay process. AUC for MTO -BSA -NP in lymph node was 3.36 folds higher than that for mitoxantrone solution ( MTO - Soln ). Conclusion : The method described here is suitable for the study of mitoxantrone distribution and pharmacokinetics in rat plasma and different tissues after sc injection of MTO - BSA - NP. MTO - BSA - NP significantly facilitated MTO to concentrate in lymph node than that of MTO - Soln.
出处 《药物分析杂志》 CAS CSCD 北大核心 2006年第8期1043-1049,共7页 Chinese Journal of Pharmaceutical Analysis
关键词 米托蒽醌 白蛋白纳米粒 体内分布 淋巴结靶向性 高效液相色谱法 mitoxantrone mitoxantrone loaded albumin nanoparticles tissue distribution lymph node targeting RP- HPLC
  • 相关文献

参考文献6

  • 1LI Shu - ling(李树玲). Breast Cancer Oncology (乳腺肿瘤学). Bei-jing(北京) :Scientific and Technical Documents Publishing House (科学技术文献出版社),2000.1
  • 2Lu Bin, Xiong Su - bin, Yang Hong, et al. Mitoxantrone - loaded BSA nanospheres and chitosan nanospheres for local injection against breast cancer and its lymph node metastases I : Formulation and in vitro characterization, Int J Pharm ,2006,307 : 168
  • 3Rentsch KM,Schwendener RA, Haenseler E. Determination of mitoxantrone in mouse whole blood and different tissues by high -performance liquid chromatography. J Chromatogr, 1996,679 : 185
  • 4Luftensteiner CP,Schwendenwein I, Paul B,et al. Evaluation of mitoxantrone- loaded albumin microspheres following intraperitoneal administration for rats, J Control Rel, 1999,57:35
  • 5Choi KE, Sinkule JA, Han DS, et al. High - performance liquid chromatographia assay for mitoxantrone in plasma using electrochemical dection. J Chromatogr , 1987,420:81
  • 6Hu OY, Novel assay method for mitoxantrone in plasma,and its application in cancer patients. J Chromatogr, 1990,532:337

同被引文献51

引证文献8

二级引证文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部